Gordon Clause Samples

Gordon. Harvey Granat
Gordon. Name: Andrew D. Gordon Title: Senior Portf▇▇▇▇ ▇▇▇▇▇▇▇ OSP FUNDING LLC By: /s/ M. Cristina Higgins ---------------------------------------------- Name: M. Cristina Higgins Title: Assistant Vi▇▇ ▇▇▇▇▇▇▇▇▇ PETRUSSE EUROPEAN CLO S.A. By: INVESCO Senior Secured Management, Inc, as Collateral Manager By: /s/ Thomas Ewald ---------------------------------------------- Name: Thomas Ewald Title: Authorized Signa▇▇▇▇ PPM GRAYHAWK CLO, LTD. By: PPM America, Inc., as Collateral Manager By: /s/ David C. Wagner ---------------------------------------------- Name: David C. Wagner Title: Managing Dire▇▇▇▇ PPM SHADOW CREEK FUNDING LLC By: /s/ M. Cristina Higgins ---------------------------------------------- Name: M. Cristina Higgins Title: Assistant Vi▇▇ ▇▇▇▇▇▇▇▇▇ QUALCOMM GLOBAL TRADING, INC. By: Morgan Stanley Investment Management, Inc. ▇▇ ▇▇▇▇stment Manager By: /s/ Jinny Kim ---------------------------------------------- Name: Jinny Kim Title: Executive Director RACE POINT IV CLO, LTD By: Sankaty Advisors, LLC, as Collateral Manager By: /s/ Alan K. Halfenger ---------------------------------------------- Name: Alan K. Halfenger Title: Chief Compl▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇ Assistant Secretary REGATTA II FUNDING LTD. By: Citigroup Alternative Investments LLC, Attorney-in-Fact By: /s/ Melanie Hanlon ---------------------------------------------- Name: Melanie Hanlon Title: Director RIVERSOURCE BOND SERIES, INC. - RIVERSOURCE FLOATING RATE FUND By: /s/ Yvonne E. Stevens ---------------------------------------------- Name: Yvonne E. Stevens Title: Assistant V▇▇▇ ▇▇▇▇▇▇▇▇▇ SANKATY ADVISORS, LLC, as Collateral Manager for Race Point CLO, Limited, as Term Lender By: /s/ Alan K. Halfenger ---------------------------------------------- Name: Alan K. Halfenger Title: Chief Compl▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇ Assistant Secretary REGATTA FUNDING LTD. By: Citigroup Alternative Investments LLC, Attorney-in-Fact By: /s/ Melanie Hanlon ---------------------------------------------- Name: Melanie Hanlon Title: Director SAGAMORE CLO LTD. By: INVESCO Senior Secured Management, Inc., as Collateral Manager By: /s/ Thomas Ewald ---------------------------------------------- Name: Thomas Ewald Title: Authorized Signa▇▇▇▇ SANKATY HIGH YIELD PARTNERS, II, L.P. By: /s/ Alan K. Halfenger ---------------------------------------------- Name: Alan K. Halfenger Title: Chief Compl▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇ Assistant SARATOGA CLO I, LIMITED By: INVESCO Senior Secured Management, Inc., as the Asset Manager By: /s/ Thomas Ewald ----...
Gordon. Its: ----------------------------------- Date: January 6, 1995 ----------------------------------- FIFTH ADDENDUM TO LEASE BY AND BETWEEN THE JOSEPH PELL AND EDA PELL REVOCABLE TRUST ("▇▇▇ ▇ANDLO▇▇") AND FAIR, ISAAC AND COMPANY, INCORPORATED ("TH▇ ▇▇▇ANT") DATED JULY 1, 1993 This Addendum to Lease dated May 24, 1995, ("Fifth Addendum") is hereby attached to and incorporated into and made a part of that Lease dated July 1, 1993, by and between The Joseph and Eda Pell Revocable Trust and Fair, Isaac and Company, Inc▇▇▇▇▇▇ted a▇▇ ▇▇▇▇▇ Addendum to Lease by and b▇▇▇▇▇n The Joseph and Eda Pell Revocable Trust and Fair, Isaac and Company, Inco▇▇▇▇▇▇ed da▇▇▇ ▇▇▇▇ 1, 1993, and Second Add▇▇▇▇▇ to Lease by and between The Joseph and Eda Pell Revocable Trust and Fair, Isaac and Company, I▇▇▇▇▇▇rated ▇▇▇▇▇ January 31, 1994, and Thir▇ ▇▇dendum to Lease by and between The Joseph and Eda Pell Revocable Trust and Fair, Isaac and Company, ▇▇▇▇▇▇orated ▇▇▇▇▇ January 31, 1994, and Four▇▇ ▇ddendum to Lease by and between The Joseph and Eda Pell Revocable Trust and Fair, Isaac and Company, I▇▇▇▇▇▇rated ▇▇▇▇▇ December 15, 1994. The parti▇▇ ▇▇ree to the following terms and conditions set forth herein below:
Gordon. Title: President and Chief Operating Officer ----------------------------------------------- CONCORD CONFECTIONS USA HOLDINGS, INC.
Gordon. 1995. In vivo analysis of cadherin function in the mouse intestinal epithelium: essential roles in adhesion, maintenance of differentiation, and regulation of program- med cell death. J. Cell Biol. 129: 489-506.
Gordon. 1996. Forced expression of E-cadherin in the mouse intestinal epithelium slows cell migration and provides evidence for nonautonomous regulation of cell fate in a self-renewing system. Genes Dev. 10:985-996. Hinck, L., I.S. Nathke, J. Papkoff, and W.J. Nelson. 1994. Dynamics of cadherin/ catenin complex formation: novel protein interactions and pathways of complex assembly. J. Cell Biol. 125:1327- 1340. Hirano, S., N. Kimoto, Y. Shimoyama, S. Hirohashi, and M. Takeichi. 1992. Identification of a neural a- catenin as a key regulator of cadherin function and multicellular organisation. Cell. 70:293-301. Hodivala, K.J., and F.M. Watt. 1994. Evidence that cadherins play a role in the downregulation of integrin expression that occurs during keratinocyte terminal differentiation. J. Cell Biol. 124:589- 600. Horan, P.K., M.J. Melnikoff, B.D. Jensen, and S.E. Slezak. 1990. Fluorescent cell labeling for in vivo and in vitro cell tracking. Methods Cell Biol. 33:469- 490. Islam, S., T.E. Carey, G.T. Wolf, M.J. Wheelock, and K.R. Johnson. 1996. Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell- cell adhesion. J. Cell Biol. 135:1643-1654. Jou, T.S., D.B. Stewart, J. Stappert, W.J. Nelson, and J.A. Marrs, 1995. Genetic and biochemical dissec- tion of protein linkages in the cadherin-catenin complex. Proc. Natl. Acad. Sci. USA. 92:5067-5071. Knudsen, K.A., A.P. Soler, K.R. Johnson, and M.J. Wheelock. 1995. Interaction of a-actinin with the cadherin/catenin cell-cell adhesion complex via a-catenin. J. Cell Biol. 130:67-77. Larue, L., C. Antos, S. Butz, O. Huber, V. Delmas, M. Dominis, and R. Kemler. 1996. A role for cadherins in tissue formation. Development (Camb.). 122: 3185-3194. Litvinov, S.V. 1995. Ep-CAM: a homophilic cell-cell adhesion molecule with EGF-like domains. Trends Glycosci. Glycotechn. 7:375-384. Litvinov, S.V., M.P. Velders, H.A.M. Bakker, G.J. Fleuren, and S.O. Warnaar. 1994a. Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule. J. Cell Biol. 125:437-446. Litvinov, S.V., H.A.M. Bakker, M.M. Gourevitch, M.P. Velders, and S.O. Warnaar. 1994b. Evidence for a role of the epithelial glycoprotein 40 (Ep-CAM) in epithelial cell-cell adhesion. Cell Adhes. Commun. 2:417-428. Litvinov, S.V., W. van Driel, C.M. van Rhijn, H.A.M. Bakker, H. van Krieken, G.J. Fleuren, and S.O. Warnaar. 1996. Expression of Ep-CAM in cervical squamous epithelia correlates with an increas...
Gordon. Its: -----------------------------------
Gordon the person who directed the formation of the Fund and served as the sole initial Manager. Interest The entire ownership interest in the Fund at any particular time of a Member or the Special Advisory Member, or other person to whom an Interest of a Member or portion thereof has been transferred pursuant to Section 3.4 hereof, including the rights and obligations of such Member or other person under this Agreement and the Delaware Act. Investment Advisory Agreement A separate written agreement entered into by the Fund pursuant to which the Adviser provides investment advisory services to the Fund. Manager An individual designated as a manager of the Fund pursuant to the provisions of Section 1.6 of the Agreement and who serves on the Board of Managers of the Fund. Member Any person who shall have been admitted to the Fund as a member (including any Manager in such person's capacity as a member of the Fund but excluding any Manager in such person's capacity as a Manager of the Fund) until the Fund repurchases the entire Interest of such person pursuant to Section 3.6 hereof or a substituted member or members are admitted with respect to any such person's entire Interest as a member pursuant to Section 3.4 hereof; such term includes the Adviser to the extent the Adviser makes a capital contribution to the Fund and shall have been admitted to the Fund as a member, but shall not include the Special Advisory Member in its capacity as such. Net Assets The total value of all assets of the Fund, less an amount equal to all accrued debts, liabilities and obligations of the Fund, calculated before giving effect to any repurchases of Interests. Net Profit or Net Loss The amount by which the Net Assets as of the close of business on the last day of a Fiscal Period exceed (in the case of Net Profit) or are less than (in the case of Net Loss) the Net Assets as of the commencement of the same Fiscal Period (or, with respect to the initial Fiscal Period of the Fund, as of the close of business on the Closing Date). 1940 Act The Investment Company Act of 1940 and the rules, regulations and orders thereunder, as amended from time to time, or any successor law. Organizational Expenses The expenses incurred by the Fund in connection with its formation, its initial registration as an investment company under the 1940 Act, and the initial offering of Interests. Organizational Member The Distributor, which contributed initial capital to the Fund prior to the Closing Date. Securit...
Gordon. Title: Portfolio Manager --------------------------------------- OCTAGON INVESTMENT PARTNERS IV, LTD. By: OCTAGON CREDIT INVESTORS, LLC As Portfolio Manager
Gordon. Title: Portfolio Manager --------------------------------------- MASS MUTUAL LIFE INSURANCE By: /s/ Steven J. Katz ------------------------------------------ Name: Steven J. Katz ---------------------------------------- Title: Second Vice President and Associate General Counsel --------------------------------------- SIMSBURY CLO LTD By: Massachusetts Mutual Life Insurance Company as Collateral Manager By: /s/ Steven J. Katz ------------------------------------------ Name: Steven J. Katz ---------------------------------------- Title: Second Vice President and Associate General Counsel --------------------------------------- PERSEUS CDO I LTD By: Massachusetts Mutual Life Insurance Co., as Collateral Manager By: /s/ Steven J. Katz ------------------------------------------ Name: Steven J. Katz ---------------------------------------- Title: Second Vice President and Associate General Counsel --------------------------------------- ARCHIMEDES FUNDING II, LTD. By: ING Capital Advisors LLC, as Collateral Manager By: /s/ Greg M. Masuda ----------------------------------------- Name: Greg M. Masuda CFA ---------------------------------------- Title: Vice President --------------------------------------- BLACK DIAMOND CLO 2000 I LTD By: /s/ Alan Corkish ------------------------------------------- Name: Alan Corkish ----------------------------------------- Title: Director ---------------------------------------- PAMCO CAYMAN LTD. By: Highland Capital Management, L.P. As Collateral Manager By: /s/ Louis Koven ------------------------------------------- Name: Louis Koven ----------------------------------------- Title: Executive Vice President - CFO ---------------------------------------- PAM CAPITAL FUNDING, L.P. By: Hig▇▇▇nd Capital Management, L.P. As Collateral Manager By: /s/ Louis Koven ------------------------------------------- Name: Louis Koven ----------------------------------------- Title: Executive Vice President - CFO ---------------------------------------- HIGHLAND LEGACY LIMITED By: Highland Capital Management, L.P. As Collateral Manager By: /s/ Louis Koven ------------------------------------------- Name: Louis Koven ----------------------------------------- Title: Executive Vice President - CFO ---------------------------------------- ML CBO IV (Cayman) Ltd. By: Highland Capital Management, L.P. As Collateral Manager By: /s/ Louis Koven ------------------------------------------- Name: Louis Koven ----------------------------------------- Title...